Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
Links shared publicly online about this topic.
- 437total visits
Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing ...
View full resource at physorg.com
Tags: Heart, Heart Disease, Circulatory Disorders, Atherosclerosis, Cholesterol, Disease and Condition
Most Recently Shared on March 15, 2011 at 2:38 pm By:
Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients http://tw.physorg.com/219403877
Microsoft Word - Press_release_MHI_Cerenis.doc
icm-mhi.org — “Microsoft Word - Press_release_MHI_Cerenis.doc” View full resource at icm-mhi.org
Most Recently Shared on March 17, 2011 at 7:59 pm By:
Symposier Cardiology Cardiology and Health Business
Potential new treatment to reduce the burden of atherosclerosis in patients with acute coronary syndrome. http://bit.ly/hXbodR
Advertisement
